Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
about
Exposure to asphalt fumes activates activator protein-1 through the phosphatidylinositol 3-Kinase/Akt signaling pathway in mouse epidermal cellsFreshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPKVanadate-induced activation of activator protein-1: role of reactive oxygen speciesNF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamideAP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation.Aspirin promotes TFF2 gene activation in human gastric cancer cell linesNonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK inductionInduction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cellsExtracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activationSuppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylateTranscription factors in the cellular signaling network as prime targets of chemopreventive phytochemicalsInhibition of transcription factors by anti-inflammatory and anti-rheumatic drugs: can variability in response be overcome?Quercetin potentiates UVB-Induced c-Fos expression: implications for its use as a chemopreventive agent.Protein kinase C modulation and anticancer drug response.Impact of acetylsalicylic Acid on the clinicopathological characteristics and prognosis of patients with invasive breast cancer.Photochemoprevention of skin cancer by botanical agents.Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.Mitogen-activated protein kinase activation in UV-induced signal transduction.Regulation of IL4 gene expression by T cells and therapeutic perspectives.Aspirin and some other nonsteroidal anti-inflammatory drugs inhibit cystic fibrosis transmembrane conductance regulator protein gene expression in T-84 cells.Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.Src Tyrosine Kinase Activation by 4-Hydroxynonenal Upregulates p38, ERK/AP-1 Signaling and COX-2 Expression in YPEN-1 Cells.Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cellsOmega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase.Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.Death in the substantia nigra: a motor tragedy.c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cellsInnate and adaptive immunity for the pathobiology of Parkinson's disease6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.Inhibition of interleukin 1β-stimulated interleukin-6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways.Salicylideneamino-2-thiophenol modulates nuclear factor-κB through redox regulation during the aging process.Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.Inhibitory action of salicylideneamino-2-thiophenol on NF-κB signaling cascade and cyclooxygenase-2 in HNE-treated endothelial cells.Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.Indometacin up-regulates TFF2 expression in gastric epithelial cells.
P2860
Q23911301-F9B76806-D1E1-4B9F-9160-547C69A7F1AAQ23918460-FD43AC8B-5E36-48E5-83E1-BF1BEBE8100FQ23918463-55E261B3-EE85-43EE-A0F5-51770FC9FC8FQ24804016-B558E5B4-35D5-404A-926A-0983FBEC1385Q24810593-35275156-14EF-4162-9480-09F4DADD0AEEQ27469944-E9BE2543-1D7A-440F-8BDF-3802D6D7BAECQ28175416-7B7FB561-479E-4EBC-8512-7ABC928003B1Q28191438-DEA633BE-D8A2-4926-870E-E5695E1B989DQ28193048-EFE8819A-EB2B-40AB-9F5F-74439880A72AQ28292778-5A6401B5-023A-47D9-8FB3-F240B0C78C45Q28343291-14F59E7F-D303-4AA1-A13B-3DADB15E4DEDQ33746771-10FFEF93-997C-40F6-A5FE-46911690AA7AQ33879436-4A54139B-21A8-4BA0-B754-1A9C0D7FA641Q34077645-7BD4AB3F-D586-4C84-A319-BB6B17D84B9AQ34099388-C0C6ABE0-1E2E-4361-8F4F-69A621D43373Q34403601-F1E27479-3852-49C3-819A-269CA5FB7A43Q34536597-8412120E-C915-4AC1-8973-41532D1568EEQ34646513-A96F7CE4-4A78-4B81-B0E1-33663CD8DE54Q35055502-DF0D8312-604C-4521-805F-9940249CF4B8Q35183154-99F7DC13-87BC-4ED4-AD9D-A0CE5FF1AF81Q35609770-35DC990A-83FB-4F03-9F3B-B8ADA380F66DQ35670500-20085160-C91E-4606-B558-A3A28F475BB7Q35747592-54960DC9-943D-405D-8595-F339432EBB7CQ35806907-5C6D9B2F-D3AB-4DD0-A28A-1E8990FCC446Q35896276-1D6EBA06-4D09-4E65-8297-CA6BA7D72CE1Q36313374-430F860A-5F1F-4403-8E74-5951CC29D2C7Q36375222-FB7BFD4F-2808-4699-A330-6774E6F2ADA5Q36631000-6B127CF4-524E-4C6E-BBB7-3E0CC24713DAQ36738131-3D5C74DA-5CEA-4392-8DA9-EFB4FC0A0FD9Q36847262-5A39762E-FD6A-45DC-8FB7-9D04F6AEAB9CQ37238650-742C5CC3-39B6-487D-946B-1D8B77FBA384Q37401280-F1377438-77A2-432A-8085-B3E4FCC2BE7BQ37626259-446E8FE8-8D13-4CCF-B6D3-8A345EE0DC11Q38132159-A81C8638-6E90-42DD-9091-B2A196E311E5Q38313361-1826D499-AF1D-4574-8286-50341ED26572Q38434797-7B98764B-D277-4F7C-957A-C565889AE8F2Q38751543-C41611DB-C62E-4FA3-ACCC-9BE82C9EEE77Q39162804-4AD44D77-EDA2-403F-861C-68CA38DE02EFQ40088825-1D872400-52B7-4D13-B862-A4D0B52D31FEQ40527721-4E940928-00C4-41C0-B43E-20A61E341CF6
P2860
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@en
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@nl
type
label
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@en
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@nl
prefLabel
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@en
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@nl
P2093
P2860
P356
P1476
Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.
@en
P2093
P2860
P304
P356
10.1074/JBC.272.15.9962
P407
P577
1997-04-01T00:00:00Z